Metastatic Triple-Negative Taxane-Resistant Breast Cancer: Investigating the Role of Bexarotene in Inducing Susceptibility to Chemotherapy by Differentiating Cancer Cells from a Mesenchymal-Like to an Epithelial-Like Phenotype

Conditions & Treatments

  • Breast Cancer

Specialty

  • Oncology

Published Date

20/10/2020

Contact Details

  • For enquiries, please email clinical.trials@nccs.com.sg

Study Description

Metastatic

Last Updated: 20 October 2020